PaulMichaelArmisteadMDPhD

Oncology • Chapel Hill, NC

Hematologic Oncology

Associate Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine

Join to view full profile

Dr. Armistead is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Armistead's full profile

Already have an account?

Office
101 Manning Dr
Chapel Hill, NC 27599
Phone+1 919-966-4131

Summary

Stem cell transplant and cellular therapy

Education & Training

University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2005 - 2008
Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
University of North Carolina at Chapel Hill School of MedicineClass of 2002

Certifications & Licensure

NC State Medical License 2008 - 2025
TX State Medical License 2005 - 2010
MA State Medical License 2004 - 2005
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients Start of enrollment: 2018 Mar 01
Completed

Publications & Presentations

PubMed

The Prevalence of Multidrug Resistance in Enterobacterales Is Higher in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Tessa M Andermann, Dylan Brown, Thomas Holowka, Luther A Bartelt, Jonathan S Serody
Open Forum Infectious Diseases. 2025-01-01
4 citations
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study.
Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou
Clinical Infectious Diseases. 2024-08-16
47 citations
Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses.
Menglin Wang, Benoit Rousseau, Kunyu Qiu, Guannan Huang, Yu Zhang
Nature Biotechnology. 2024-08-01

Abstracts/Posters

Age-Associated Changes in the Respiratory Epithelial Response to Influenza Infection
Paul Armistead, MD, The Journals of Gerontology, Orlando, FL, 12/7/2019

Press Mentions

Press Ganey Recognizes UNC Health in 2024 Human Experience AwardsJanuary 29th, 2025
North Carolina 6-Year-Old Searching for Bone Marrow DonorDecember 11th, 2024
Could Baking Soda Fight Leukemia Relapse After Stem Cell Transplant?January 5th, 2021
Join now to see all